ADIPOQ and Obesity: An intervention study conducted by Aye et al. in a mouse model of obesity in pregnancy shows that using synthetic adiponectin receptor agonist may be a helpful intervention treatment to increase functional adiponectin on maternal and placental tissues to reduce the metabolic and hormonal complications due to maternal obesity and GDM (24).